Rehabilitation program for patients recovering from COVID-19
Evaluation of Influence of Proprietary Physical Training Program on Quality of Life, Physical Endurance, Function of Muscles and Myokines Profile in Patients After COVID-19 Infection.
This study tests a six-week rehab program to see if it can help people who have recovered from COVID-19 feel better physically and mentally.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 60 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Medical University of Bialystok Academic / other |
| Locations | 1 site (Białystok, Podlaskie) |
| Trial ID | NCT05449379 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effectiveness of a six-week physical training and respiratory rehabilitation program for outpatients who have recovered from COVID-19. Conducted at the Medical University of Bialystok, it involves 60 participants who will undergo various assessments including physical examinations, quality of life surveys, and biochemical analyses. The program aims to improve symptoms, physical endurance, and mental health in individuals who experienced COVID-19 within the last year.
Who should consider this trial
Good fit: Ideal candidates are adults over 18 who have had a confirmed COVID-19 infection within the last 12 months and are experiencing mild to moderate symptoms.
Not a fit: Patients with severe pulmonary diseases or other serious health conditions that prevent participation in rehabilitation may not benefit from this study.
Why it matters
Potential benefit: If successful, this program could significantly enhance the quality of life and physical capabilities of patients recovering from COVID-19.
How similar studies have performed: Other studies have shown promising results with rehabilitation programs for COVID-19 recovery, indicating that this approach is supported by existing evidence.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * COVID 19 infection confirmed with a positive PCR (polymerase chain reaction) SARS-CoV-2 (Severe Scute Respiratory Syndrome coronavirus type 2) test less than 12 moths prior to intervention * more than 14 days from the day of obtaining a positive PCR test result for SARS-CoV-2 or discharge from hospital. * mMRC (modified Medical Research Council) score ≥1 * age \>18 years * informed consent signed by patient to conduct the study Exclusion Criteria: * severe pulmonary disease (e.g. COPD) * the functional state that makes it impossible to carry out the pre-examination and improvement program * severe chest pain * worsening dyspnea * hemoptysis * worsening dry cough * syncope * worsening oedema of extremities * myocarditis (less than 6 months from acute phase)
Where this trial is running
Białystok, Podlaskie
- Medical University of Bialystok, Department of Rehabilitation — Białystok, Podlaskie, Poland (Recruiting)
Study contacts
- Study coordinator: Mariusz Ciolkiewicz, PhD
- Email: mariusz.ciolkiewicz@umb.edu.pl
- Phone: 858318315
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.